English | EN 
With the calm precision of a scientist, Dr. Joost Fledderus—biologist at Utrecht University—took the stage to explore how artificial intelligence is reshaping life sciences and healthcare. His talk, rich with real examples and ethical reflections, connected operating rooms, stem-cell labs, and even jellyfish genes in one sweeping story about the fusion of biology and AI.
The question whether the audience was ready to undergo surgery conducted by an autonomous AI-system without the intervention by a doctor was negatively answered by the majority (48%), while 29% was not sure and a courageous 23% said yes.
From Science Fiction to Surgery
Fledderus began by reminding the audience that AI in medicine is no longer a futuristic fantasy. “It’s already in the clinic,” he said, “helping — not replacing — doctors.” He described how radiologists now use AI to detect anomalies on X-rays and MRI scans with greater precision. “With AI, the diagnosis improves — but notice I said ‘with,’ not ‘by.’ It’s a partnership,” he stressed. AI doesn’t take over; it assists. Surgeons, too, are gaining new “digital eyes.” In some hospitals, AI systems analyze tissue during operations, identifying whether all cancerous cells have been removed before the patient even leaves the operating table. Meanwhile, patients at home are increasingly monitored through wearables that feed data into AI models, alerting doctors to irregularities long before a crisis develops. “The line between hospital and home is fading,” he noted. “AI has
made healthcare both more personal and more preventive.”
Repairing the Heart—Literally
From here, Fledderus moved to his passion: regenerative medicine—the science of helping the body repair itself. At Utrecht’s Regenerative Medicine Center, where 300 researchers work on restoring damaged organs and tissues, the dream is no longer metaphorical. “When I say, ‘healing the heart,’ I mean it quite literally.” He explained how researchers grow heart muscle cells from stem cells, embed them into a patch, and place that patch over damaged tissue. The challenge, he joked, is not unlike a marriage:
“You want the new cells to integrate fully, to beat in sync, and not start doing their own
thing.” Though still in animal trials, the results are promising—the next step is human testing, a milestone that could redefine recovery for heart patients.
The AI-Enhanced Scientist
AI, Fledderus explained, is revolutionizing not just treatment but also the way science itself is done. Traditional research is slow and linear: hypothesis, experiment, analysis, publication. AI turns this into a loop of constant iteration. He introduced the audience to the Agentic Scientist — an AI trained on the complete works of longevity researcher Aubrey de Grey. “It now helps him generate new research questions,” he said. “Imagine your younger self, but smarter, faster, and with a perfect memory.” AI is also
cutting through red tape. Where researchers once had to read hundreds of papers for a meta-analysis, AI now digests and summarizes the literature in hours. In laboratories, systems like the “Chemputer” can synthesize new chemical compounds automatically from written instructions. “You feed it the recipe for amolecule,” Fledderus explained, “and it literally cooks it for you.”
The Universe Inside a Cell
Fledderus then zoomed in—literally—to the cellular level. On screen appeared an image of the human intestine, glowing in colors that looked more like a Monet painting than medical science. “This is real tissue,” he said, “but we made it glow by borrowing a fluorescent protein from a jellyfish.” The room chuckled. “Yes, we are all a little bit jellyfish now,” he added dryly. But these visual techniques, while spectacular, distort the natural state of the cell. So, scientists are now training AI models to analyze tissue
without dyes or genetic modification. “AI can learn to see structure and function directly from raw light data—no color tricks needed.” The result? A more accurate, more humane form of microscopy. He also showed how AI-guided drug screening for cystic fibrosis uses patient stem cells grown into organoids — tiny mini-organs — to determine the best combination of medicines in weeks instead of years. “That’s personalized medicine,” he said. “Not an average cure, but your cure.”
Data, Education, and Ethics
All this innovation, Fledderus warned, creates a tidal wave of data. “Every cell is a universe,” he said. “And now we’re trying to map billions of them.” The challenge isn’t generating data — it’s understanding it. He championed the idea of explainable AI: “We don’t just want the answer. We want to know why it’s the answer.” Students, he added with a grin, already use ChatGPT — no matter what their professors think. “Should we ban it? No. We should teach them to challenge it. Let them use AI but train them to doubt it.” Teachers, he argued, will become coaches rather than oracles. The real skill of the next generation will be critical evaluation — knowing when to trust the algorithm and when to question it.
The Moral Frontier
As the talk shifted toward ethics, Fledderus struck a thoughtful tone. With the ability to
manipulate DNA, design organs, and perhaps extend human life, medicine now faces
profound questions. “If we can repair everything,” he asked, “should we?” He cited
concerns over designer genetics — choosing traits like eye color or intelligence — and the
blurred line between therapy and enhancement. “Do we use these tools because they heal,” he asked, “or because they perfect?” Responsibility, he emphasized, cannot be outsourced. “If AI makes a wrong diagnosis, you can’t sue the algorithm. You made the choice to use it. The accountability stays with us.”
Of Longevity and Limits
When asked about world leaders reportedly seeking eternal life, Fledderus smiled wryly. “I
think they already act as if they’re immortal,” he quipped. He acknowledged that longevity
research is advancing rapidly — especially around reducing inflammation, which
accelerates aging — but warned of a moral dilemma: “If some people live forever while
others can’t afford antibiotics, we have a problem.” Would he want eternal life himself?
“Absolutely not,” he said. “It sounds boring. Use your years wisely — that’s long enough.”
Looking Ahead
To conclude, Fledderus painted a vision of the near future. Digital twins — virtual replicas of our bodies — will simulate treatments before they’re applied. Blockchain-based biobanks will secure our biological data ethically. And quantum biology may help answer the oldest question of all: how does life begin? His final message was equal parts optimism and humility:
“We already have the tools to cure most diseases. What we lack is time —create and
wisdom. AI can give us the first, but we must provide the second.” The audience applauded warmly, not just for the promise of the science, but for the reminder that even in the age of intelligent machines, the heartbeat of progress remains human.
Get your copy of the Autopilot Yes/No Report.
Please note – This report was created by almost exclusively using available AI-tools except for minor editorial tweaks and some limited lay-out changes.